Fred E Cohen - Net Worth and Insider Trading
Fred E Cohen Net Worth
The estimated net worth of Fred E Cohen is at least $5 Million dollars as of 2024-04-26. Fred E Cohen is the Director of Genomic Health Inc and owns about 73,532 shares of Genomic Health Inc (GHDX) stock worth over $5 Million. Fred E Cohen is the Director of BioCryst Pharmaceuticals Inc and owns about 119,410 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $506,298. Fred E Cohen is also the Director of Veracyte Inc and owns about 0 shares of Veracyte Inc (VCYT) stock worth over $0. Details can be seen in Fred E Cohen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Fred E Cohen has not made any transactions after 2020-05-18 and currently still holds the listed stock(s).
Transaction Summary of Fred E Cohen
Fred E Cohen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Fred E Cohen owns 10 companies in total, including Veracyte Inc (VCYT) , CareDx Inc (CDNA) , and Intellia Therapeutics Inc (NTLA) among others .
Click here to see the complete history of Fred E Cohen’s form 4 insider trades.
Insider Ownership Summary of Fred E Cohen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VCYT | Veracyte Inc | 2020-05-18 | director |
| CDNA | CareDx Inc | 2015-07-01 | director |
| NTLA | Intellia Therapeutics Inc | 2019-01-23 | director |
| URGN | UroGen Pharma Ltd | 2019-01-01 | director |
| PGNY | Progyny Inc | 2021-10-24 | director |
| TNDM | Tandem Diabetes Care Inc | 2013-11-13 | director |
| BCRX | BioCryst Pharmaceuticals Inc | 2017-09-18 | director |
| ROKA | Sorrento Tech Inc | 2017-06-28 | director |
| FPRX | Five Prime Therapeutics Inc | 2017-05-10 | director |
| IQV | IQVIA Holdings Inc | 2013-05-08 | director |
Fred E Cohen Latest Holdings Summary
Fred E Cohen currently owns a total of 3 stocks. Among these stocks, Fred E Cohen owns 73,532 shares of Genomic Health Inc (GHDX) as of November 8, 2018, with a value of $5 Million and a weighting of 90.21%. Fred E Cohen owns 119,410 shares of BioCryst Pharmaceuticals Inc (BCRX) as of September 18, 2017, with a value of $506,298 and a weighting of 9.79%. Fred E Cohen also owns 0 shares of Veracyte Inc (VCYT) as of May 18, 2020, with a value of $0 and a weighting of 0%.
Latest Holdings of Fred E Cohen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GHDX | Genomic Health Inc | 2018-11-08 | 73,532 | 63.44 | 4,664,870 |
| BCRX | BioCryst Pharmaceuticals Inc | 2017-09-18 | 119,410 | 4.24 | 506,298 |
| VCYT | Veracyte Inc | 2020-05-18 | 0 | 19.54 | 0 |
Holding Weightings of Fred E Cohen
Fred E Cohen Form 4 Trading Tracker
According to the SEC Form 4 filings, Fred E Cohen has made a total of 0 transactions in Genomic Health Inc (GHDX) over the past 5 years. The most-recent trade in Genomic Health Inc is the sale of 10,000 shares on November 8, 2018, which brought Fred E Cohen around $879,300.
According to the SEC Form 4 filings, Fred E Cohen has made a total of 0 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years. The most-recent trade in BioCryst Pharmaceuticals Inc is the sale of 54,250 shares on September 18, 2017, which brought Fred E Cohen around $294,035.
According to the SEC Form 4 filings, Fred E Cohen has made a total of 1 transactions in Veracyte Inc (VCYT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Veracyte Inc is the sale of 40,000 shares on May 18, 2020, which brought Fred E Cohen around $1 Million.
Insider Trading History of Fred E Cohen
- 1
Fred E Cohen Trading Performance
Fred E Cohen Ownership Network
Ownership Network List of Fred E Cohen
Ownership Network Relation of Fred E Cohen
Fred E Cohen Owned Company Details
What does Veracyte Inc do?
Who are the key executives at Veracyte Inc?
Fred E Cohen is the director of Veracyte Inc. Other key executives at Veracyte Inc include Chief Scientific & Med Officer Phillip G. Febbo , Chief Commercial Officer-CLIA John Leite , and director & President & CEO Bonnie H Anderson .
Veracyte Inc (VCYT) Insider Trades Summary
Over the past 18 months, Fred E Cohen made no insider transaction in Veracyte Inc (VCYT). Other recent insider transactions involving Veracyte Inc (VCYT) include a net sale of 75,004 shares made by Evan/ Fa Jones , a net sale of 245,247 shares made by Bonnie H Anderson , and a net sale of 2,048 shares made by Giulia C Kennedy .
In summary, during the past 3 months, insiders sold 10,000 shares of Veracyte Inc (VCYT) in total and bought 0 shares, with a net sale of 10,000 shares. During the past 18 months, 368,481 shares of Veracyte Inc (VCYT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 368,481 shares.
Veracyte Inc (VCYT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Veracyte Inc Insider Transactions
Fred E Cohen Mailing Address
Above is the net worth, insider trading, and ownership report for Fred E Cohen. You might contact Fred E Cohen via mailing address: 301 Commerce Street, Suite 3300, Fort Worth Tx 76102.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
